Asia Pacific Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type , Treatment Type , Distribution Channel , and Country: Trend Forecast and Growth Opportunity

You are here: Home Catalog Pharma & Healthcare Treatments Diseases

Asia Pacific Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type , Treatment Type , Distribution Channel , and Country: Trend Forecast and Growth Opportunity

Market Research Report Summary

Asia Pacific Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type , Treatment Type , Distribution Channel , and Country: Trend Forecast and Growth Opportunity report is published on April 30, 2022 and has 93 pages in it. This 91制片厂 report provides information about Treatments, Diseases, Pharma & Healthcare industry. It covers Asia Pacific market data and forecasts. It is priced starting at USD 2,800.00 for Single User License (PDF) which allows one person to use this report.

Please read the description and table of contents of this research report given below to check whether it meets your research requirements. If not, then please do not hesitate to contact us using "Report Enquiry" form given below. We can customize this research report or suggest a new fully customized 91制片厂 report to meet your research goals and data requirements.

Asia Pacific Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type , Treatment Type , Distribution Channel , and Country: Trend Forecast and Growth Opportunity

Printer version

Send by email

Publication ID:听

GRM0422028

Publication Date:听

April 30, 2022

笔补驳别蝉:听

93

笔耻产濒颈蝉丑别谤:听

Grace Market Data

颁辞耻苍迟谤颈别蝉:听

Asia Pacific

USD 2,800.00

Pay By Invoice

If you wish to purchase this report using bank/wire transfer against an invoice, please fill your details using request invoice form given below.

Globally Trusted Brand

We help executives from firms听to Start-ups听with their 91制片厂 needs thus听we can help you too.听

Secure Checkout

You can shop confidently as your online payments are processed using PCI DSS compliant secure payment gateways on our website.

Frequently Asked Questions

If you have any pre-sales听questions related to this report please let us know using the "Report Enquiry" form below. This will help us provide you听with answers听so that you can purchase with confidence. If you wish to read about frequently asked questions by our customers please visit our .

Tabs

Description

Asia Pacific onychomycosis treatment market will grow by 9.3% annually with a total addressable market cap of $10,998.9 million over 2022-2031, driven by the increasing prevalence of chronic medical ailments, the growing geriatric population, improved therapies and preventative solutions, and the rising healthcare expenditure.
Highlighted with 28 tables and 39 figures, this 93-page report 鈥淎sia Pacific Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific onychomycosis treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� Market Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & Market Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific onychomycosis treatment market in every aspect of the classification from perspectives of Onychomycosis Type, Treatment Type, Distribution Channel, and Country.

Based on Onychomycosis Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Distal Subungual Onychomycosis
鈥� White Superficial Onychomycosis
鈥� Proximal Subungual Onychomycosis
鈥� Candidal Onychomycosis
鈥� Other Onychomycosis Types

Based on Treatment Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Drug Treatment
鈥� Laser Therapy
鈥� Photodynamic Therapy
鈥� Other Therapies

By Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Hospitals and Clinics
鈥� Online Stores
鈥� Retail Pharmacies
鈥� Other Distribution Channels

Geographically, the following national/local markets are fully investigated:
鈥� Japan
鈥� China
鈥� South Korea
鈥� Australia
鈥� India
鈥� Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Onychomycosis Type, Treatment Type and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Bausch Health Companies Inc.
Bayer AG
Cipla Ltd
Dr. Reddys Laboratories Ltd
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Lumenis Ltd
Medimetriks Pharmaceuticals Inc.
Moberg Pharma AB
Novartis AG
Pfizer Inc.
Sanofi SA
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the Market 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter鈥檚 Fiver Forces Analysis 36
3 Segmentation of Asia Pacific Market by Onychomycosis Type 40
3.1 Market Overview by Onychomycosis Type 40
3.2 Distal Subungual Onychomycosis 42
3.3 White Superficial Onychomycosis 43
3.4 Proximal Subungual Onychomycosis 44
3.5 Candidal Onychomycosis 45
3.6 Other Onychomycosis Types 46
4 Segmentation of Asia Pacific Market by Treatment Type 47
4.1 Market Overview by Treatment Type 47
4.2 Drug Treatment 49
4.3 Laser Therapy 50
4.4 Photodynamic Therapy 51
4.5 Other Therapies 52
5 Segmentation of Asia Pacific Market by Distribution Channel 53
5.1 Market Overview by Distribution Channel 53
5.2 Hospitals and Clinics 55
5.3 Online Stores 56
5.4 Retail Pharmacies 57
5.5 Other Distribution Channels 58
6 Asia-Pacific Market 2021-2031 by Country 59
6.1 Overview of Asia-Pacific Market 59
6.2 Japan 62
6.3 China 65
6.4 Australia 67
6.5 India 69
6.6 South Korea 71
6.7 Rest of APAC Region 73
7 Competitive Landscape 75
7.1 Overview of Key Vendors 75
7.2 New Product Launch, Partnership, Investment, and M&A 78
7.3 Company Profiles 79
Bausch Health Companies Inc. 79
Bayer AG 81
Cipla Ltd 82
Dr. Reddys Laboratories Ltd 83
Galderma SA 84
GlaxoSmithKline PLC 85
Johnson & Johnson 86
Lumenis Ltd 87
Medimetriks Pharmaceuticals Inc. 88
Moberg Pharma AB 89
Novartis AG 90
Pfizer Inc. 91
Sanofi SA 92
RELATED REPORTS 93

Companies Covered

Selected Key Players:
Bausch Health Companies Inc.
Bayer AG
Cipla Ltd
Dr. Reddys Laboratories Ltd
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Lumenis Ltd
Medimetriks Pharmaceuticals Inc.
Moberg Pharma AB
Novartis AG
Pfizer Inc.
Sanofi SA
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Enquiry / Request Invoice

Report Inquiry

Do you have more questions related to this 91制片厂 report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

First Name *

Last Name *

Company *

Email Address *

Phone (Including International Code) *

Report Title *

Do you need invoice for purchasing this report? *

Address 1

Address 2

City/Town

Postal/Zip Code

Country

License Type

Your Inquiry *

CAPTCHA

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Treatments

Diseases

Pharma & Healthcare

*Please note that the report cover image shown above is for representation purpose only. Actual report cover may vary.

听

Related Market Research Reports

Publication	Price
South Asia and Southeast Asia Collagen Dental Bone Graft Market Report & Forecast 2024-2030 The South Asia and Southeast Asia Collagen Dental Bone Graft revenue was US$ xx million in 2023 and is forecast to a readjusted size of US$ xx million by 2030 with a CAGR of xx% during the review period (2025-2030). The South Asia Collagen Dental Bone Graft revenue was US$ xx million in 2023 and is forecast to a readjusted size of US$ xx million by 2030 with a CAGR of xx% during the review period (2025-2030). The Southeast Asia Collagen Dental Bone Graft revenue was US$ xx million in 2023 and is forecast to a readjusted size of US$ xx million by 2030 with a CAGR of xx% during the review period (2025-2030). The key players of Collagen Dental Bone Graft in South Asia include Collagen Matrix, Sunmax Biotechnology, OSSIX, MBI, ACRO Biomedical, Horien Biochemcial, and etc. The five biggest players in South Asia hold a share of xx % in 2023. The key players of Collagen Dental Bone Graft in Southeast Asia include Collagen Matrix, Sunmax Biotechnology...Read more	USD 6,000.00
Business Opportunities and Investment Strategies for Global Soft Tissue Repair Market 2023-2033 Opportunity and Strategy Analysis This report focuses on identifying opportunities and strategies for investing in the global soft tissue repair market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter鈥檚 Fiver Forces analysis. Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the soft tissue repair industry and...Read more	USD 3,800.00
Asia Pacific Cellulite Treatment Market 2022-2032 by Cellulite Type , Technology , Treatment Type , End User , and Country: Trend Forecast and Growth Opportunity Asia Pacific cellulite treatment market will grow by 11.8% annually with a total addressable market cap of $8,436.6 million over 2023-2032, driven by the increasing prevalence of obesity due to sedentary lifestyles and improper diet, the creation of cutting-edge products and technologies, the enormous rise in popularity of non-invasive and minimally invasive aesthetic procedures, and the supportive government initiatives. Highlighted with 30 tables and 48 figures, this 103-page report 鈥淎sia Pacific Cellulite Treatment Market 2022-2032 by Cellulite Type (Soft, Hard, Edematous), Technology (Non-Invasive, Minimally Invasive, Topical, Others), Treatment Type (Energy Based, Non-energy Based), End User (Hospitals, SDCs, CSCs), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific cellulite treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are...Read more	USD 2,600.00
Global Endometrial Ablation Market 2022-2032 by Offering , Technology , End User , and Region: Trend Forecast and Growth Opportunity Global endometrial ablation market will reach $4,065.8 million by 2032, growing by 4.7% annually over 2022-2032, driven by the huge prevalence of Gynecological disorders and growing cases of cervical cancer, emergence of next generation ablation procedures and minimally invasive surgical techniques, the benefits of Endometrial Ablation over Hysterectomy (surgical removal of the uterus), growing adoption of ablation procedures, and the government initiatives for the development of the healthcare sector. Highlighted with 81 tables and 70 figures, this 145-page report 鈥淕lobal Endometrial Ablation Market 2022-2032 by Offering (Devices, Procedures), Technology (Radiofrequency, Cryoablation, Hydrothermal, Thermal Balloon, Hysteroscopic, Microwave Energy, Electrical), End User (Hospitals, Clinics, ASCs), and Region: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire global endometrial ablation market and all its sub-segments through extensively...Read more	USD 3,400.00
North America Endometrial Ablation Market 2022-2032 by Offering , Technology , End User , and Country: Trend Forecast and Growth Opportunity North America endometrial ablation market is projected to grow by 4.4% annually in the forecast period and reach $1,751.6 million by 2032, driven by the huge prevalence of Gynecological disorders and growing cases of cervical cancer, emergence of next generation ablation procedures and minimally invasive surgical techniques, the benefits of Endometrial Ablation over Hysterectomy (surgical removal of the uterus), growing adoption of ablation procedures, and the government initiatives for the development of the healthcare sector. Highlighted with 22 tables and 34 figures, this 83-page report 鈥淣orth America Endometrial Ablation Market 2022-2032 by Offering (Devices, Procedures), Technology (Radiofrequency, Cryoablation, Hydrothermal, Thermal Balloon, Hysteroscopic, Microwave Energy, Electrical), End User (Hospitals, Clinics, ASCs), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire North America endometrial ablation market and...Read more	USD 2,800.00

Clients Who Trust Us

Need tailor made 91制片厂 solution? We can help you with that too.

Contact Us

About Us

At 91制片厂. we aim to make it easier for decision makers to find relevant information and locate right 91制片厂 reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global 91制片厂 firms who are known leaders in their respective domains to obtain right 91制片厂 solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

91制片厂
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

Disclaimer: 91制片厂. has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom 91制片厂 from our website MarketResearchReports.com only.

If you are looking for a 91制片厂 solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our 91制片厂 consultants or directly write to us.

91制片厂